Professor Andrew Cope
Professor of Rheumatology
- Head of the Centre for Rheumatic Diseases
Research interests
- Immunology
Contact details
Biography
Andrew Cope graduated in Medicine from the University of London with First Class Honours.
After training in general internal medicine at Northwick Park Hospital, The National Hospital for Nervous Diseases and the Royal Brompton Hospital, he trained in rheumatology with Professor Sir Ravinder Maini and Dr Barbara Ansell CBE.
In 1990, he was awarded a Wellcome Trust Clinical Training Fellowship, studying for a PhD in Cytokine Biology with Professor Marc Feldmann at the Kennedy Institute of Rheumatology. Following a postdoctoral fellowship with Prof Hugh McDevitt at Stanford University, California, studying transgenic models of autoimmunity, he returned to the Kennedy Institute to set up his own laboratory.
Research
Lipids and Membranes Research Interest Group
A Lipids and Membranes Research Interest Group
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
News
Clinical trial shows rheumatoid arthritis drug could prevent disease
A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk.
Just one in three people with gout prescribed preventative medication
Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.
Centre for Rheumatic Diseases recognised as Centre for Excellence
The Centre has been named by the European League Against Rheumatism (EULAR) as one of the top research centres in Europe for rheumatology research.
Research
Lipids and Membranes Research Interest Group
A Lipids and Membranes Research Interest Group
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
News
Clinical trial shows rheumatoid arthritis drug could prevent disease
A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk.
Just one in three people with gout prescribed preventative medication
Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.
Centre for Rheumatic Diseases recognised as Centre for Excellence
The Centre has been named by the European League Against Rheumatism (EULAR) as one of the top research centres in Europe for rheumatology research.